Comparison of HIV risk by duration of injection drug use

Substance Use and Misuse

Volumn 46, Issue 2-3, 2011, Pages 181-191

  Vlahov, David ^a   C Ompad, Danielle ^a   M Fuller, Crystal ^a   Nandi, Vijay ^a  

^a NONE

Author keywords

adolescent and young adults; epidemiology; HIV; injection; substance use

Indexed keywords

ADULT; ARTICLE; DRUG USE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; RISK; SUBSTANCE ABUSE; TIME; UNITED STATES;

ADULT; DRUG USERS; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INTERVIEWS AS TOPIC; NEW YORK CITY; RISK; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 79951571072     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.521466     Document Type: Article

References (58)

1. Abelson, J., Treloar, C., Crawford, J., Kippax, S., van, B.I., & Howard, J.(2006).Some characteristics of early-onset injection drug users prior to and at the time of their first injection.Addiction, 101, 548-555. (Pubitemid 43375618)
2. Amon, J.J., Garfein, R.S., Ahdieh-Grant, L., Armstrong, G.L., Ouellet, L.J., Latka, M.H., et al.(2008).Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.Clinical Infectious Diseases, 46, 1852-1858.
3. Becker Buxton, M., Vlahov, D., Strathdee, S.A., Des Jarlais, D.C., Morse, E.V., Ouellet, L., et al.(2004).Association between injection practices and duration of injection among recently initiated injection drug users.Drug and Alcohol Dependence, 75(2), 177-183. (Pubitemid 38970125)
4. Bryant, J., & Treloar, C.(2007).The gendered context of initiation to injecting drug use: Evidence for women as active initiates.Drug and Alcohol Review, 26, 287-293.
5. Bryant, J., & Treloar, C.(2008).Initiators: An examination of young injecting drug users who initiate others to injecting.AIDS and Behavior, 12, 885-890.
6. Carneiro,M., Fuller, C., Doherty, M.C., & Vlahov, D.(1999).HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old.Drug and Alcohol Dependence, 54, 83-86. (Pubitemid 29073381)
7. Chang, C.J., Lin, C.H., Lee, C.T., Chang, S.J., Ko, Y.C., & Liu, H.W.(1999).Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan.European Journal of Epidemiology, 15, 597-601.
8. Deren, S., Kang, S.Y., Colon, H.M., Andia, J.F., & Robles, R.R.(2004).HIV incidence among high-risk Puerto Rican drug users: A comparison of East Harlem, New York, and Bayamon, Puerto Rico.Journal of Acquired Immune Deficiency Syndromes, 36, 1067-1074. (Pubitemid 38989373)
9. Des Jarlais, D.C., Arasteh, K., Perlis, T., Hagan, H., Heckathorn, D.D., Mcknight, C., et al.(2007).The transition from injection to non-injection drug use: Long-term outcomes among heroin and cocaine users in New York City.Addiction, 102, 778-785. (Pubitemid 46633361)
10. Des Jarlais, D.C., Casriel, C., Friedman, S.R., & Rosenblum, A.(1992).AIDS and the transition to illicit drug injection-Results of a randomized trial prevention program.British Journal of Addiction, 87, 493-498.
11. Des Jarlais, D.C., Diaz, T., Perlis, T., Vlahov, D., Maslow, C., Latka, M., et al.(2003).Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City.American Journal of Epidemiology, 157, 467-471. (Pubitemid 36258602)
12. Des Jarlais, D.C., & Friedman, S.R.(1998).Fifteen years of research on preventing HIV infection among injecting drug users: What we have learned, what we have not learned, what we have done,whatwe have not done.Public Health Reports, 113(Suppl.1), 182-188. (Pubitemid 29330159)
13. Des Jarlais, D.C., Friedman, S.R., & Hopkins, W.(1985).Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.Annals of Internal Medicine, 103, 755-759. (Pubitemid 16218400)
14. Des Jarlais, D.C., Friedman, S.R., Perlis, T., Chapman, T.F., Sotheran, J.L., Paone, D., et al.(1999).Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(1), 67-72. (Pubitemid 29045472)
15. Des Jarlais, D.C., & Semaan, S.(2008).HIV prevention for injecting drug users: the first 25 years and counting.Psychosomatic Medicine, 70, 606-611.
16. Doherty, M.C., Garfein, R.S., Monterroso, E., Brown, D., & Vlahov, D.(2000a).Correlates of HIV infection among young adult short-term injection drug users.AIDS, 14, 717-726. (Pubitemid 30229351)
17. Doherty, M.C., Garfein, R.S., Monterroso, E., Latkin, C., & Vlahov, D.(2000b).Gender differences in the initiation of injection drug use among young adults.Journal of Urban Health, 77, 396-414. (Pubitemid 30658853)
18. Dolan, K.A., & Niven, H.(2005).A review of HIV prevention among young injecting drug users: A guide for researchers.Harm Reduction Journal, 2, 5.
19. Dunn, J., & Laranjeira, R.R.(1999).Transitions in the route of cocaine administration: Characteristics, direction and associated variables.Addiction, 94, 813-824. (Pubitemid 29286602)
20. Fennema, J.S., van Ameijden, E.J., Van Den, H.A., & Coutinho, R.A.(1997).Young and recent-onset injecting drug users are at higher risk for HIV.Addiction, 92, 1457-1465. (Pubitemid 27499558)
21. Frajzyngier, V., Neaigus, A., Gyarmathy, V.A., Miller, M., & Friedman, S.R.(2007).Gender differences in injection risk behaviors at the first injection episode.Drug and Alcohol Dependence, 89(2-3), 145-152. (Pubitemid 46754670)
22. Friedman, S.R., Des Jarlais, D.C., Neaigus, A., bdul-Quader, A., Sotheran, J.L., Sufian, M., et al.(1989).AIDS and the new drug injector.Nature, 339, 333-334.
23. Fuller, C.M., Ompad, D.C., Galea, S., Wu, Y., Koblin, B., & Vlahov, D.(2004).Hepatitis C incidence: A comparison between injection and noninjection drug users in New York City.Journal of Urban Health, 81(1), 20-24. (Pubitemid 38622996)
24. Fuller, C.M., Vlahov, D., Latkin, C.A., Ompad, D.C., Celentano, D.D., & Strathdee, S.A.(2003).Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users.Journal of Acquired Immune Deficiency Syndromes, 32, 86-93. (Pubitemid 36091490)
25. Fuller, C.M., Vlahov, D., Ompad, D.C., Shah, N., Arria, A., & Strathdee, S.A.(2002b).High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: A case-control study.Drug and Alcohol Dependence, 66, 189-198. (Pubitemid 34242896)
26. Garfein, R.S., Doherty, M.C., Monterroso, E.R., Thomas, D.L., Nelson, K.E., & Vlahov, D.(1998).Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl.1), S11-S19. (Pubitemid 28304463)
27. Garfein, R.S., Golub, E.T., Greenberg, A.E., Hagan, H., Hanson, D.L., Hudson, S.M., et al.(2007).A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.AIDS, 21(14), 1923-1932. (Pubitemid 47329769)
28. Garfein, R.S., Vlahov, D., Galai, N., Doherty, M.C., & Nelson, K.E.(1996).Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.American Journal of Public Health, 86, 655-661. (Pubitemid 26145477)
29. Garten, R.J., Lai, S., Zhang, J., Liu,W., Chen, J., Vlahov, D., et al.(2004).Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China.International Journal of Epidemiology, 33, 182-188. (Pubitemid 38500175)
30. Hagan, H., Pouget, E.R., Des Jarlais, D.C., & Lelutiu-Weinberger, C.(2008).Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: The influence of time and place.American Journal of Epidemiology, 168, 1099-1109.
31. Kelley, M.S.& Chitwood, D.D.(2004).Effects of drug treatment for heroin sniffers: A protective factor against moving to injection? Social Science and Medicine, 58, 2083-2092. (Pubitemid 38326984)
32. Kleinig, J.,&Einstein, S.(2006).Ethical challenges for intervening in drug use: Policy, research and treatment issues.Huntsville, TX: OICJ.
33. Mathers, B.M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S.A., et al.(2008).Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review.Lancet, 372, 1733-1745.
34. McCurdy, S.A., Ross, M.W., Kilonzo, G.P., Leshabari, M.T., & Williams,M.L.(2006).HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam, Tanzania.Drug and Alcohol Dependence, 82(Suppl.1), S23-S27. (Pubitemid 43850173)
35. Miller, K.W., Wilder, L.B., Stillman, F.A., & Becker, D.M.(1997).The feasibility of a street-intercept survey method in an African-American community.American Journal of Public Health, 87, 655-658.
36. Moatti, J.P., Vlahov, D., Feroni, I., Perrin, V., & Obadia, Y.(2001).Multiple access to sterile syringes for injection drug users:Vendingmachines, needle exchange programs and legal pharmacy sales inMarseille, France.European Addiction Research,7, 40-45. (Pubitemid 32337199)
37. Neaigus, A., Gyarmathy, V.A., Miller, M., Frajzyngier, V.M., Friedman, S.R., & Des Jarlais, D.C.(2006).Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility.Journal of Acquired Immune Deficiency Syndromes, 41(4), 493-503.
38. Needle, R.H., Coyle, S., Cesari, H., Trotter, R., Clatts,M., Koester, S., et al.(1998).HIV risk behaviors associated with the injection process: Multiperson use of drug injection equipment and paraphernalia in injection drug user networks.Substance Use and Misuse, 33, 2403-2423. (Pubitemid 28460899)
39. Nelson, K.E., Vlahov, D., Solomon, L., Cohn, S., & Munoz, A.(1995).Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD.Archives of Internal Medicine, 155, 1305-1311.
40. Nicolosi,A., Leite,M.L., Musicco,M., Molinari, S.,&Lazzarin,A.(1992). Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion.The Northern Italian Seronegative Drug Addicts (NISDA) Study.American Journal of Epidemiology, 135, 225-233.
41. Novelli, L.A., Sherman, S.G., Havens, J.R., Strathdee, S.A., & Sapun, M.(2005).Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users.Drug and Alcohol Dependence, 77, 303-309. (Pubitemid 40283532)
42. Ompad, D.C., Galea, S., Marshall, G., Fuller, C.M., Weiss, L., Beard, J.R., et al.(2008).Sampling and recruitment in multilevel studies among marginalized urban populations: The IMPACT studies.Journal of Urban Health, 85, 268-280.
43. Sanchez, J., Chitwood, D.D., & Koo, D.J.(2006).Risk factors associated with the transition from heroin sniffing to heroin injection: A street addict role perspective.Journal of Urban Health, 83, 896-910. (Pubitemid 44310356)
44. Solomon, L., Astemborski, J., Warren, D., Munoz, A., Cohn, S., Vlahov, D., et al.(1993).Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users.American Journal of Epidemiology, 137, 892-898. (Pubitemid 23149667)
45. Stern, R.K., Hagan, H., Lelutiu-Weinberger, C., Des Jarlais, D., Scheinmann, R., Strauss, S., et al.(2008).The HCV Synthesis Project: Scope, methodology, and preliminary results.BMC Medical Research Methodology, 8(62), 62.
46. Tarabar, A.F., & Nelson, L.S.(2003).The resurgence and abuse of heroin by children in the United States.Current Opinion in Pediatrics, 15, 210-215. (Pubitemid 36337835)
47. Uusküla, A., Kals, M., Rajaleid, K., Abel, K., Talu, A., Ruutel, K., et al.(2008).High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: Need for large-scale prevention programs.Journal of Public Health (Oxford), 30, 119-125.
48. van Ameijden, E.J., van den Hoek, J.A., Hartgers, C., & Coutinho, R.A.(1994).Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users.American Journal of Epidemiology, 139, 1153-1163. (Pubitemid 24184409)
49. Vlahov, D., Anthony, J.C., Celentano, D., Solomon, L., & Chowdhury, N.(1991).Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987.American Journal of Drug and Alcohol Abuse, 17, 39-48.
50. Vlahov, D., Des Jarlais, D.C., Goosby, E., Hollinger, P.C., Lurie, P.G., Shriver, M.D., et al.(2001).Needle exchange programs for the prevention of human immunodeficiency virus infection: Epidemiology and policy.American Journal of Epidemiology, 15, 154(12 Suppl), S70-S77. (Pubitemid 33144494)
51. Vlahov, D., Fuller, C.M., Ompad, D.C., Galea, S., & Des Jarlais, D.C.(2004a).Updating the infection risk reduction hierarchy: Preventing transition into injection.Journal of Urban Health, 81, 14-19. (Pubitemid 38622995)
52. Vlahov, D., Munoz, A., Anthony, J.C., Cohn, S., Celentano, D.D., & Nelson, K.E.(1990).Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland.American Journal of Epidemiology, 132, 847-856. (Pubitemid 20363663)
53. Vlahov, D., Wang, C.L., Galai, N., Bareta, J., Mehta, S.H., Strathdee, S.A., et al.(2004b).Mortality risk among new onset injection drug users.Addiction, 99, 946-954. (Pubitemid 39452806)
54. Vlahov, D.,Wang, C., Ompad, D., Fuller, C.M., Caceres,W., Ouellet, L., et al.(2008).Mortality risk among recent-onset injection drug users in five US cities.Substance Use and Misuse, 43, 413-428. (Pubitemid 351448738)
55. Weiker, R.L., Edgington, R., & Kipke, M.D.(1999).A collaborative evaluation of a needle exchange program for youth.Health Education and Behavior, 26, 213-224.
56. Weiss, L., Ompad, D., Galea, S., & Vlahov, D.(2007).Defining neighborhood boundaries for urban health research.American Journal of Preventive Medicine, 32, S154-S159. (Pubitemid 46817868)
57. Winick C.( 1962).Maturing out of narcotic addiction.Bulletin on Narcotics, 14, 1- 7.Retrieved March 7, 2010, from -
58. Witteveen, E., van Ameijden, E.J., & Schippers, G.M.(2006).Motives for and against injecting drug use among young adults in Amsterdam: Qualitative findings and considerations for disease prevention.Substance Use and Misuse, 41, 1001-1016. (Pubitemid 43995144)